sj pharmacare limited
sj pharmacare limited Company Information
Company Number
11442313
Next Accounts
Jan 2026
Industry
Other human health activities
Shareholders
shree patel
Group Structure
View All
Contact
Registered Address
hillingdon house, mc patel & co, 386-388 kenton road, harrow, middlesex, HA3 9DP
Website
www.aspenpharma.comsj pharmacare limited Estimated Valuation
Pomanda estimates the enterprise value of SJ PHARMACARE LIMITED at £48.6k based on a Turnover of £106.6k and 0.46x industry multiple (adjusted for size and gross margin).
sj pharmacare limited Estimated Valuation
Pomanda estimates the enterprise value of SJ PHARMACARE LIMITED at £120k based on an EBITDA of £34.5k and a 3.48x industry multiple (adjusted for size and gross margin).
sj pharmacare limited Estimated Valuation
Pomanda estimates the enterprise value of SJ PHARMACARE LIMITED at £277.3k based on Net Assets of £112.9k and 2.46x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Sj Pharmacare Limited Overview
Sj Pharmacare Limited is a live company located in harrow, HA3 9DP with a Companies House number of 11442313. It operates in the other human health activities sector, SIC Code 86900. Founded in July 2018, it's largest shareholder is shree patel with a 100% stake. Sj Pharmacare Limited is a young, micro sized company, Pomanda has estimated its turnover at £106.6k with healthy growth in recent years.
Upgrade for unlimited company reports & a free credit check
Sj Pharmacare Limited Health Check
Pomanda's financial health check has awarded Sj Pharmacare Limited a 3.5 rating. We use a traffic light system to show it exceeds the industry average on 4 measures and has 4 areas for improvement. Company Health Check FAQs
4 Strong
2 Regular
4 Weak
Size
annual sales of £106.6k, make it smaller than the average company (£571.3k)
- Sj Pharmacare Limited
£571.3k - Industry AVG
Growth
3 year (CAGR) sales growth of 13%, show it is growing at a faster rate (8.3%)
- Sj Pharmacare Limited
8.3% - Industry AVG
Production
with a gross margin of 22.2%, this company has a higher cost of product (38.5%)
- Sj Pharmacare Limited
38.5% - Industry AVG
Profitability
an operating margin of 32.3% make it more profitable than the average company (5.6%)
- Sj Pharmacare Limited
5.6% - Industry AVG
Employees
with 2 employees, this is below the industry average (14)
- Sj Pharmacare Limited
14 - Industry AVG
Pay Structure
on an average salary of £27k, the company has an equivalent pay structure (£27k)
- Sj Pharmacare Limited
£27k - Industry AVG
Efficiency
resulting in sales per employee of £53.3k, this is equally as efficient (£50.9k)
- Sj Pharmacare Limited
£50.9k - Industry AVG
Debtor Days
it gets paid by customers after 8 days, this is earlier than average (21 days)
- Sj Pharmacare Limited
21 days - Industry AVG
Creditor Days
its suppliers are paid after 230 days, this is slower than average (16 days)
- Sj Pharmacare Limited
16 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Sj Pharmacare Limited
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Sj Pharmacare Limited
- - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 83.6%, this is a higher level of debt than the average (27%)
83.6% - Sj Pharmacare Limited
27% - Industry AVG
SJ PHARMACARE LIMITED financials
Sj Pharmacare Limited's latest turnover from April 2024 is estimated at £106.6 thousand and the company has net assets of £112.9 thousand. According to their latest financial statements, we estimate that Sj Pharmacare Limited has 2 employees and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Apr 2024 | Apr 2023 | Apr 2022 | Apr 2021 | Apr 2020 | Apr 2019 | |
|---|---|---|---|---|---|---|
| Turnover | ||||||
| Other Income Or Grants | ||||||
| Cost Of Sales | ||||||
| Gross Profit | ||||||
| Admin Expenses | ||||||
| Operating Profit | ||||||
| Interest Payable | ||||||
| Interest Receivable | ||||||
| Pre-Tax Profit | ||||||
| Tax | ||||||
| Profit After Tax | ||||||
| Dividends Paid | ||||||
| Retained Profit | ||||||
| Employee Costs | ||||||
| Number Of Employees | 1 | 1 | ||||
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Apr 2024 | Apr 2023 | Apr 2022 | Apr 2021 | Apr 2020 | Apr 2019 | |
|---|---|---|---|---|---|---|
| Tangible Assets | 687,565 | 687,565 | 687,565 | 687,565 | 687,565 | 687,565 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 687,565 | 687,565 | 687,565 | 687,565 | 687,565 | 687,565 |
| Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Debtors | 2,605 | 1,866 | 465 | 417 | 336 | 4,167 |
| Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 |
| Misc Debtors | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | 0 | 0 | 0 | 0 | 0 | 0 |
| misc current assets | 0 | 0 | 0 | 0 | 0 | 0 |
| total current assets | 2,605 | 1,866 | 465 | 417 | 336 | 4,167 |
| total assets | 690,170 | 689,431 | 688,030 | 687,982 | 687,901 | 691,732 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 52,319 | 52,700 | 52,692 | 52,222 | 50,674 | 1,211 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 |
| other short term finances | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 0 | 0 | 0 | 0 | 0 | 0 |
| total current liabilities | 52,319 | 52,700 | 52,692 | 52,222 | 50,674 | 1,211 |
| loans | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 524,971 | 549,712 | 577,313 | 606,711 | 635,149 | 689,815 |
| provisions | 0 | 0 | 0 | 0 | 0 | 0 |
| total long term liabilities | 524,971 | 549,712 | 577,313 | 606,711 | 635,149 | 689,815 |
| total liabilities | 577,290 | 602,412 | 630,005 | 658,933 | 685,823 | 691,026 |
| net assets | 112,880 | 87,019 | 58,025 | 29,049 | 2,078 | 706 |
| total shareholders funds | 112,880 | 87,019 | 58,025 | 29,049 | 2,078 | 706 |
| Apr 2024 | Apr 2023 | Apr 2022 | Apr 2021 | Apr 2020 | Apr 2019 | |
|---|---|---|---|---|---|---|
| Operating Activities | ||||||
| Operating Profit | ||||||
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 |
| Amortisation | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax | ||||||
| Stock | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors | 739 | 1,401 | 48 | 81 | -3,831 | 4,167 |
| Creditors | -381 | 8 | 470 | 1,548 | 49,463 | 1,211 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash flow from operations | ||||||
| Investing Activities | ||||||
| capital expenditure | ||||||
| Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 |
| cash flow from investments | ||||||
| Financing Activities | ||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | 0 | 0 | 0 | 0 | 0 | 0 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | -24,741 | -27,601 | -29,398 | -28,438 | -54,666 | 689,815 |
| share issue | ||||||
| interest | ||||||
| cash flow from financing | ||||||
| cash and cash equivalents | ||||||
| cash | 0 | 0 | 0 | 0 | 0 | 0 |
| overdraft | 0 | 0 | 0 | 0 | 0 | 0 |
| change in cash | 0 | 0 | 0 | 0 | 0 | 0 |
sj pharmacare limited Credit Report and Business Information
Sj Pharmacare Limited Competitor Analysis
Perform a competitor analysis for sj pharmacare limited by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other micro companies, companies in HA3 area or any other competitors across 12 key performance metrics.
sj pharmacare limited Ownership
SJ PHARMACARE LIMITED group structure
Sj Pharmacare Limited has 1 subsidiary company.
Ultimate parent company
SJ PHARMACARE LIMITED
11442313
1 subsidiary
sj pharmacare limited directors
Sj Pharmacare Limited currently has 2 directors. The longest serving directors include Mr Jayvin Patel (Jul 2018) and Mrs Shree Patel (Jul 2018).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Jayvin Patel | England | 36 years | Jul 2018 | - | Director |
| Mrs Shree Patel | England | 35 years | Jul 2018 | - | Director |
P&L
April 2024turnover
106.6k
0%
operating profit
34.5k
0%
gross margin
22.3%
+5.29%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
April 2024net assets
112.9k
+0.3%
total assets
690.2k
0%
cash
0
0%
net assets
Total assets minus all liabilities
Similar Companies
sj pharmacare limited company details
company number
11442313
Type
Private limited with Share Capital
industry
86900 - Other human health activities
incorporation date
July 2018
age
6
incorporated
UK
ultimate parent company
accounts
Micro-Entity Accounts
last accounts submitted
April 2024
previous names
N/A
accountant
-
auditor
-
address
hillingdon house, mc patel & co, 386-388 kenton road, harrow, middlesex, HA3 9DP
Bank
-
Legal Advisor
-
sj pharmacare limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to sj pharmacare limited.
sj pharmacare limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for SJ PHARMACARE LIMITED. This can take several minutes, an email will notify you when this has completed.
sj pharmacare limited Companies House Filings - See Documents
| date | description | view/download |
|---|
